ARTICLE | Clinical News
Mifamurtide regulatory update
October 6, 2008 7:00 AM UTC
IDM said that after a meeting with EMEA's CHMP and Secretariat the company now expects an opinion from CHMP on its MAA for mifamurtide (L-MTP-PE) to treat non-metastatic, resectable osteosarcoma in No...